[HTML][HTML] Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions

M Ghezzi, S Pescina, C Padula, P Santi… - Journal of Controlled …, 2021 - Elsevier
Polymeric micelles, ie aggregation colloids formed in solution by self-assembling of
amphiphilic polymers, represent an innovative tool to overcome several issues related to …

PLGA-based nanoparticles in cancer treatment

S Rezvantalab, NI Drude, MK Moraveji… - Frontiers in …, 2018 - frontiersin.org
Nanomedicines can be used for a variety of cancer therapies including tumor-targeted drug
delivery, hyperthermia, and photodynamic therapy. Poly (lactic-co-glycolic acid)(PLGA) …

Polymerization of ethylene oxide, propylene oxide, and other alkylene oxides: synthesis, novel polymer architectures, and bioconjugation

J Herzberger, K Niederer, H Pohlit, J Seiwert… - Chemical …, 2016 - ACS Publications
The review summarizes current trends and developments in the polymerization of alkylene
oxides in the last two decades since 1995, with a particular focus on the most important …

The importance of nanoparticle shape in cancer drug delivery

NP Truong, MR Whittaker, CW Mak… - Expert opinion on drug …, 2015 - Taylor & Francis
Introduction: Nanoparticles have been successfully used for cancer drug delivery since
1995. In the design of commercial nanoparticles, size and surface characteristics have been …

Antibiofouling polymer interfaces: poly (ethylene glycol) and other promising candidates

S Lowe, NM O'Brien-Simpson, LA Connal - Polymer Chemistry, 2015 - pubs.rsc.org
Nonspecific protein adsorption and/or microbial adsorption on biomedical materials
adversely affects the efficacy of a range of biomedical systems, from implants and …

Non-lamellar lyotropic liquid crystalline lipid nanoparticles for the next generation of nanomedicine

J Zhai, C Fong, N Tran, CJ Drummond - ACS nano, 2019 - ACS Publications
Nonlamellar lyotropic liquid crystalline (LLC) lipid nanomaterials have emerged as a
promising class of advanced materials for the next generation of nanomedicine, comprising …

State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines

CM Dawidczyk, C Kim, JH Park, LM Russell… - Journal of Controlled …, 2014 - Elsevier
The ability to efficiently deliver a drug to a tumor site is dependent on a wide range of
physiologically imposed design constraints. Nanotechnology provides the possibility of …

The design of poly (lactide-co-glycolide) nanocarriers for medical applications

D Essa, PPD Kondiah, YE Choonara… - … in bioengineering and …, 2020 - frontiersin.org
Polymeric biomaterials have found widespread applications in nanomedicine, and poly
(lactide-co-glycolide),(PLGA) in particular has been successfully implemented in numerous …

PLGA-based nanoparticles for the treatment of cancer: current strategies and perspectives

M Alvi, A Yaqoob, K Rehman, SM Shoaib, MSH Akash - AAPS Open, 2022 - Springer
Research on cancer treatment is always of great importance because of the extensive and
difficult treatment options and side effects of chemotherapeutic agents. Due to this, novel …

Effect of surface properties on liposomal siRNA delivery

Y Xia, J Tian, X Chen - Biomaterials, 2016 - Elsevier
Liposomes are one of the most widely investigated carriers for siRNA delivery. The surface
properties of liposomal carriers, including the surface charge, PEGylation, and ligand …